| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9aa4d7ac4628b72dd48dd67f6a436fc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea6d60f98af43b256aeea13a9e9d4f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012a4af3dc4ad350c812db1b2033023a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37921984385c542f90ed65cbd2a5521c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3992b7cadf85ff1b8f723b338e5e6b4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce4dda065a91f5f285e46d159672f05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0492f6b1fa856ffe98d5e77e18e22d74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c202ba185cc5f7e0c458f91a1f964d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7566deb1afabe1ddfd24c7db9a973320 |
| publicationDate |
2019-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201904973-A |
| titleOfInvention |
Coumarin ring-like compound as MEK inhibitor and application thereof |
| abstract |
The present invention discloses a class of coumarin-like compounds as MEK inhibitors and pharmaceutical compositions containing such compounds, and their application in the preparation of a medicament for treating MEK-related diseases. The compound of formula (I) and its pharmaceutically acceptable salt or tautomers are specifically disclosed. |
| priorityDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |